Systemic sclerosis induces pronounced peripheral vascular dysfunction characterized by blunted peripheral vasoreactivity and endothelial dysfunction

Clinical Rheumatology

Volumn 34, Issue 5, 2015, Pages 905-913

  Frech, Tracy ^a   Walker, Ashley E ^a   Barrett O’Keefe, Zachary ^b   Hopkins, Paul N ^a   Richardson, Russell S ^a,b,c   Wray, D Walter ^a,b,c   Donato, Anthony J ^a,b,c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Flow mediated dilation; Imaging; Rheumatic diseases; Scleroderma; Specialty fields; Systemic sclerosis; Ultrasound; Vasculopathy

Indexed keywords

BRACHIAL ARTERY; CASE CONTROL STUDY; COMPLICATION; DIAGNOSTIC IMAGING; ECHOGRAPHY; FEMALE; HUMAN; HYPEREMIA; MALE; MIDDLE AGED; ORGAN SIZE; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASES; PHYSIOLOGY; SYSTEMIC SCLEROSIS; VASCULAR ENDOTHELIUM; VASODILATATION;

BRACHIAL ARTERY; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPEREMIA; MALE; MIDDLE AGED; ORGAN SIZE; PERIPHERAL VASCULAR DISEASES; SCLERODERMA, SYSTEMIC; ULTRASONOGRAPHY; VASODILATION;

EID: 84939980472     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-014-2834-5     Document Type: Article

References (51)

1. Guiducci S, Distler O, Distler JH, Matucci-Cerinic M (2008) Mechanisms of vascular damage in SSc—implications for vascular treatment strategies. Rheumatology (Oxford) 47(Suppl 5):v18–v20
2. Sgonc R, Gruschwitz MS, Dietrich H, Recheis H, Gershwin ME, Wick G (1996) Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J Clin Invest 98(3):785–792
3. Frech TM, Revelo MP, Drakos SG, Murtaugh MA, Markewitz BA, Sawitzke AD et al (2012) Vascular leak is a central feature in the pathogenesis of systemic sclerosis. J Rheumatol 39(7):1385–1391
4. Kahaleh B (2008) The microvascular endothelium in scleroderma. Rheumatology (Oxford) 47(Suppl 5):v14–v15
5. Wigley FM (2009) Vascular disease in scleroderma. Clin Rev Allergy Immunol 36(2–3):150–175
6. Harris RA, Nishiyama SK, Wray DW, Richardson RS (2010) Ultrasound assessment of flow-mediated dilation. Hypertension 55(5):1075–1085
7. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID et al (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340(8828):1111–1115
8. Donato AJ, Eskurza I, Silver AE, Levy AS, Pierce GL, Gates PE et al (2007) Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-kappaB. Circ Res 100(11):1659–1666
9. Patterson GC, Whelan RF (1955) Reactive hyperaemia in the human forearm. Clin Sci (Lond) 14(2):197–211
10. Blair DA, Glover WE, Roddie IC (1959) The abolition of reactive and post-exercise hyperaemia in the forearm by temporary restriction of arterial inflow. J Physiol 148:648–658
11. Trojanowska M (2010) Cellular and molecular aspects of vascular dysfunction in systemic sclerosis. Nat Rev Rheumatol 6(8):453–460
12. Strange G, Nash P (2009) The manifestations of vasculopathy in systemic sclerosis and its evidence-based therapy. Int J Rheum Dis 12(3):192–206
13. (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23(5):581–590
14. LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28(7):1573–1576
15. Eskurza I, Monahan KD, Robinson JA, Seals DR (2004) Effect of acute and chronic ascorbic acid on flow-mediated dilatation with sedentary and physically active human ageing. J Physiol 556(Pt 1):315–324
16. Harris RA, Nishiyama SK, Wray DW, Tedjasaputra V, Bailey DM, Richardson RS (2009) The effect of oral antioxidants on brachial artery flow-mediated dilation following 5 and 10 min of ischemia. Eur J Appl Physiol 107(4):445–453
17. Rossi P, Granel B, Marziale D, Le Mee F, Frances Y (2010) Endothelial function and hemodynamics in systemic sclerosis. Clin Physiol Funct Imaging 30(6):453–459
18. Witman MA, Fjeldstad AS, McDaniel J, Ives SJ, Zhao J, Barrett-O’Keefe Z et al (2012) Vascular function and the role of oxidative stress in heart failure, heart transplant, and beyond. Hypertension 60(3):659–668
19. Walker AE, Kaplon RE, Lucking SM, Russell-Nowlan MJ, Eckel RH, Seals DR (2012) Fenofibrate improves vascular endothelial function by reducing oxidative stress while increasing endothelial nitric oxide synthase in healthy normolipidemic older adults. Hypertension 60(6):1517–1523
20. Harris MF, Bailey L, Snowdon T, Litt J, Smith JW, Joyner B et al (2010) Developing the guidelines for preventive care - two decades of experience. Aust Fam Physician 39(1–2):63–65
21. Donald AE, Halcox JP, Charakida M, Storry C, Wallace SM, Cole TJ et al (2008) Methodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation. J Am Coll Cardiol 51(20):1959–1964
22. Dinenno FA, Tanaka H, Monahan KD, Clevenger CM, Eskurza I, DeSouza CA et al (2001) Regular endurance exercise induces expansive arterial remodelling in the trained limbs of healthy men. J Physiol 534(Pt 1):287–295
23. Joyner MJ, Dietz NM, Shepherd JT (2001) From Belfast to Mayo and beyond: the use and future of plethysmography to study blood flow in human limbs. J Appl Physiol (1985) 91(6):2431–2441
24. Huang AL, Silver AE, Shvenke E, Schopfer DW, Jahangir E, Titas MA et al (2007) Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery. Arterioscler Thromb Vasc Biol 27(10):2113–2119
25. Lieberman EH, Gerhard MD, Uehata A, Selwyn AP, Ganz P, Yeung AC et al (1996) Flow-induced vasodilation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease. Am J Cardiol 78(11):1210–1214
26. Endo T, Imaizumi T, Tagawa T, Shiramoto M, Ando S, Takeshita A (1994) Role of nitric oxide in exercise-induced vasodilation of the forearm. Circulation 90(6):2886–2890
27. Takahashi T, Asano Y, Amiya E, Hatano M, Tamaki Z, Ozeki A et al (2012) Improvement of endothelial function in parallel with the amelioration of dry cough and dyspnea due to interstitial pneumonia by intravenous cyclophosphamide pulse therapy in patients with systemic sclerosis: a preliminary report of two cases. Mod Rheumatol 22(4):598–601
28. Engelke KA, Halliwill JR, Proctor DN, Dietz NM, Joyner MJ (1996) Contribution of nitric oxide and prostaglandins to reactive hyperemia in human forearm. J Appl Physiol (1985) 81(4):1807–1814
29. Kilbom A, Wennmalm A (1976) Endogenous prostaglandins as local regulators of blood flow in man: effect of indomethacin on reactive and functional hyperaemia. J Physiol 257(1):109–121
30. Carlsson I, Sollevi A, Wennmalm A (1987) The role of myogenic relaxation, adenosine and prostaglandins in human forearm reactive hyperaemia. J Physiol 389:147–161
31. Poredos P, Jezovnik MK (2013) Testing endothelial function and its clinical relevance. J Atheroscler Thromb 20(1):1–8
32. Hatton N, Frech T, Smith B, Sawitzke A, Scholand MB, Markewitz B (2011) Transforming growth factor signalling: a common pathway in pulmonary arterial hypertension and systemic sclerosis. Int J Clin Pract Suppl 172:35–43
33. Lekakis JP, Papamichael CM, Vemmos CN, Voutsas AA, Stamatelopoulos SF, Moulopoulos SD (1998) Peripheral vascular endothelial dysfunction in patients with angina pectoris and normal coronary arteriograms. J Am Coll Cardiol 31(3):541–546
34. Cypiene A, Laucevicius A, Venalis A, Dadoniene J, Ryliskyte L, Petrulioniene Z et al (2008) The impact of systemic sclerosis on arterial wall stiffness parameters and endothelial function. Clin Rheumatol 27(12):1517–1522
35. Soltesz P, Der H, Kerekes G, Szodoray P, Szucs G, Danko K et al (2009) A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima-media in patients with systemic autoimmune diseases. Clin Rheumatol 28(6):655–662
36. Bots ML, Westerink J, Rabelink TJ, de Koning EJ (2005) Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response. Eur Heart J 26(4):363–368
37. D’Andrea A, Stisi S, Caso P, Uccio FS, Bellissimo S, Salerno G et al (2007) Associations between left ventricular myocardial involvement and endothelial dysfunction in systemic sclerosis: noninvasive assessment in asymptomatic patients. Echocardiography 24(6):587–597
38. Rollando D, Bezante GP, Sulli A, Balbi M, Panico N, Pizzorni C et al (2010) Brachial artery endothelial-dependent flow-mediated dilation identifies early-stage endothelial dysfunction in systemic sclerosis and correlates with nailfold microvascular impairment. J Rheumatol 37(6):1168–1173
39. Andersen GN, Mincheva-Nilsson L, Kazzam E, Nyberg G, Klintland N, Petersson AS et al (2002) Assessment of vascular function in systemic sclerosis: indications of the development of nitrate tolerance as a result of enhanced endothelial nitric oxide production. Arthritis Rheum 46(5):1324–1332
40. Roustit M, Simmons GH, Baguet JP, Carpentier P, Cracowski JL (2008) Discrepancy between simultaneous digital skin microvascular and brachial artery macrovascular post-occlusive hyperemia in systemic sclerosis. J Rheumatol 35(8):1576–1583
41. Mathai SC, Hassoun PM (2012) Pulmonary arterial hypertension in connective tissue diseases. Heart Fail Clin 8(3):413–425
42. Inaba Y, Chen JA, Bergmann SR (2010) Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis. Int J Cardiovasc Imaging 26(6):631–640
43. Lekakis J, Mavrikakis M, Papamichael C, Papazoglou S, Economou O, Scotiniotis I et al (1998) Short-term estrogen administration improves abnormal endothelial function in women with systemic sclerosis and Raynaud’s phenomenon. Am Heart J 136(5):905–912
44. Giannattasio C, Pozzi M, Gardinali M, Montemerlo E, Citterio F, Maestroni S et al (2007) Effects of prostaglandin E1alpha cyclodextrin [corrected] treatment on endothelial dysfunction in patients with systemic sclerosis. J Hypertens 25(4):793–797
45. Sfikakis PP, Papamichael C, Stamatelopoulos KS, Tousoulis D, Fragiadaki KG, Katsichti P et al (2007) Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis. Arthritis Rheum 56(6):1985–1993
46. Mullen MJ, Kharbanda RK, Cross J, Donald AE, Taylor M, Vallance P et al (2001) Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo: relevance to endothelial dysfunction in hypercholesterolemia. Circ Res 88(2):145–151
47. Trinity JD, Groot HJ, Layec G, Rossman MJ, Ives SJ, Runnels S et al (2012) Nitric oxide and passive limb movement: a new approach to assess vascular function. J Physiol 590(Pt 6):1413–1425
48. Neunteufl T, Heher S, Kostner K, Mitulovic G, Lehr S, Khoschsorur G et al (2002) Contribution of nicotine to acute endothelial dysfunction in long-term smokers. J Am Coll Cardiol 39(2):251–256
49. Frey PF, Ganz P, Hsue PY, Benowitz NL, Glantz SA, Balmes JR et al (2012) The exposure-dependent effects of aged secondhand smoke on endothelial function. J Am Coll Cardiol 59(21):1908–1913
50. Pinnamaneni K, Sievers RE, Sharma R, Selchau AM, Gutierrez G, Nordsieck EJ et al (2014) Brief exposure to secondhand smoke reversibly impairs endothelial vasodilatory function. Nicotine Tob Res 16(5):584–590
51. Castro SV, Jimenez SA (2010) Biomarkers in systemic sclerosis. Biomark Med 4(1):133–147